Head and Neck Carcinoma Clinical Trials & Research at Providence Medical Group

Head and neck cancers start in the tissues and organs of the head and neck and include cancers of the larynx (voice box), throat, lips, mouth, nose, and salivary glands. Most head and neck cancers are squamous cell carcinomas and begin in the moist tissues that line the mouth, nose and throat. Tobacco use, heavy alcohol use, and infection with the human papillomavirus (HPV) increase your risk of head and neck cancer.

Providence Medical Group is currently enrolling patients for the following head and neck carcinoma clinical trial:

A study for patients with head and neck recurrent or metastatic cancer of the oropharynx, oral cavity, hypopharynx, and larynx

Treatment agent: Magrolimab
Physician: Ian Anderson, MD
Study Coordinator: Melissa Ulrich // melissa.ulrich@providence.org // 707-521-3830
Study Resources: Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma - Full Text View - ClinicalTrials.gov
Sponsor: Gilead Sciences
Location: Providence Cancer Center Santa Rosa, CA